04*dm This study examined Ike association between the presence of tricuspid regurgitation and immediate and late adverse outcomes in patients undergoing balloon mitral valvulophuty.
Bac& m J Significant tricuspid regurgitation has an adverse Impact on morbidity and mortality it, patients undergoing mitral valve surgery for nitral stenosis .
IFetiteds. We studled 318 consecutive patients (mean [*SD] age 54 t 15 yarn) who underwent balloon mitral valvuloplasty and had color Doppler echocardlographic studies before the procedure . Patients were classified into three groups : 221 with no or mild (0%), 60 with moderate (19%) and 37 with severe (12%) tricuspid r "urg itation. Clinical follow-up ranged from 6 to 62 months.
Resatds. Before mitral valvuloplasty, Increasing degrees of tricuspid regurgitation were associated with a smaller initial mitral valve area (p < 0 .05), higher echocardiegraphic score (p < 0.05), lower cardiac output (p < 0.01) and higher pulmonary Severe mitral stenosis is frequently associated with significant tricuspid regurgitation (1) (2) (3) (4) (5) . Retrospective studies (5-10) have indicated that significant residual tricuspid regurgitation after mitral valve surgery is associated with increased morbidity and mortality. As a consequence, it has become surgical practice to correct significant residual tricuspid regurgitation at the time of mitral valve surgery, especially after the introduction of the DeVega annuloplasty technique with its favorable results (6, 11, 12) .
Recently, percutaneous mitral balloon valvuloplasty has become an accepted alternative to surgery for the treatment of vascular resistance (p < 0 .01) . Although the initial success rate did not direr significantly between groups, patients with a higher degree or tricuspid regurgitation had less optimal results, as reflected by a smaller absolute increase in mitral valve area (1 .02 vs. 0.9 vs. 0.7 cm2, p < 0.01). The estimated 4-year event-free survival rate (freedom from death, mitral valve surgery, repeat valvuloplasty and heart failure) was lower for the group with severe tricuspid regurgitation (68% vs . 58% vs. 35%, p < 0.0001) .
At 4 years, 94% of patients with mild tricuspid regurgitation were alive compared with 90m and 69%, respectively, of patients with moderate or severe tricuspid regurgitation (p < 0 .0001) . Cox proportional analysis Identified tricuspid regurgitation as an independent predictor of late outcome (p < 0.001) .
Conclusions, Patients with mitral stenosis and severe tricuspid regurgitation undergoing mitral vahuloplasty have advanced mitral valve and pulmonary vascular disease, suboptimal immediate results and poor late outcome.
(J Am Coll Cardiol 1994;24:696-702) mitral stenosis (13, 14) . Although attractive in many respects, this new technique has the potential disadvantage that residual tricuspid regurgitation may persist after the procedure, especially when the lesion has contributed to irreversible right heart dilation or is of organic origin .
Because of these concerns, we evaluated the association between the presence of tricuspid regurgitation before mitral valvuloplasty and immediate and long-term adverse outcomes in patients with different degrees of tricuspid regurgitation who underwent balloon mitral valvuloplasty at our institution over a period of 5 years.
Methods
Study group. We studied a total of 318 consecutive patients (16) .
Echocardiographic analysis . A complete two-dimensional and Doppler color flow echocardiographic examination was performed <24 h before balloon mitral valvuloplasty using a Hewlett-Packard 77 2 A ultrasound imager equipped with a 2 .5-MHz phased array transducer . Standard echocardiographic images were obtained. A previously described semiquantitative echocardiographic assessment of mitral valve score (17) was obtained in each patient by assigning values of to 4 (with increasing abnormality) to each of four morphologic characteristics of the valve : leaflet mobility, thickening, calcification and subvalvular thickening (score range (1 to 16) .
Assessment of severity of tricuspid regtugitatiou . Tricuspid regurgitation was routinely assessed by integrating both Doppler color flow mapping images of the regurgitant jet and pulsed wave Doppler evidence of systolic flow reversal in the inferior vena cava or hepatic veins (18) . Careful Doppler evaluation of the jet was performed in all obtainable views of the right ventricle and atrium, including the parasternal short-axis view at the aortic valve level, the right ventricular inflow view, the apical four-chamber view and subcostal views . The color flow mapping display of reversed or mosaic signals originating from the tricuspid valve and extending into the right atrium during systole identified the presence of tricuspid regurgitation . The narrowest sector angle encompassing the regurgitant jet was used to obtain maximal frame rate . The area of disturbed flow that was traced (using a Sony off-line analysis system) included the aliased signals as well as the immediately contiguous nonturbulent velocities moving in the same direction as the jet . Planimetry was performed only if maximal jet area was visually estimated to be more than a minimal 1 % of the right atrial area ; it was performed in 114 patients . Right atrial area was traced from the same frame as the maximal jet area .
Tricuspid regurgitation was then graded as mild, moderate or severe according to the following algorithm . 1) The view was selected in which the spatial distribution of the jet was maximal .
2) The severity of regurgitation was graded as mild if the jet area was estimated to occupy <2 % of the right atrial area, as moderate if this value was between 2 % and 33% and as severe if it was >33%, based on correlations with surgical and angiographic severity in previous studies (19) (20) (21) . 3) If the estimated ratio of jet area to right atrial area was close to a cutoff point, jet eccentricity increased the grade above that cutoff point to the next higher grade (22, 23) because eccentric wall jets appear smaller than comparable free jets . 4) Systolic flow reversal in the inferior vena cava or hepatic veins by pulsed wave Doppler echocardiography was considered to indicate at least moderate regurgitation regardless of the other findings (2 ) . Tricuspid regurgitation was defined as organic if there was thickening, doming or restricted motion of the valve leaflets .
Clinical follow-up. Clinical follow-up ranged from 6 to 62 months (mean 26.7 ± 18 .4) . Data were obtained during patient visits to clinic or by telephone interviews conducted by a Data are presented as mean value SI) or number (''i ) of patients . NYI IA class = New York Ileart Association functional class .
(69%) with no or mild, 6 (19%) with with severe tricuspid regurgitation .
Cardiac catheterization. All patients underwent balloon mitral valvuloph.d~y ' y the transseptal approach . Complete right and left heart catheterization and oximetry studies were performed before and after balloon mitral valvuloplasty to evaluate the changes in hemodynamic variables produced by balloon mitral valvuloplasty and the presence and degree of left to right shunting through the created atrial communication . Blood samples were obtained from the superior vena cava, pulmonary artery and aorta before and after the procedure in all patients . Left to right shunting through the created atrial communication was diagnosed when there was a ?7% step-up between superior vena cava and pulmonary artery samples in repeated samples . Significant tricuspid regurgitation was diagnosed by clinical, Doppler echocardiographic and hemodynamic findings.
Cardiac output was measured using the thermodilution technique in patients without or with only mild tricuspid regurgitation . In the patients with significant (moderate or severe) tricuspid regurgitation or a left to right shunt, or both, cardiac output was measured by using the Fick principle . In the presence of tricuspid regurgitation, pulmonary artery saturation was used as mixed sample in the calculation of cardiac output . The superior vena cava saturation was used as mixed sample when a left to right shunt across the created atrial communication was present . Oxygen consumption was measured using an MRM-2 oxygen consumption monitor (Waters Instrument Inc .) . Mitral valve area was determined using the Gorlin formula (15) . Successful balloon mitral valvuloplasty was defined as a final mitral valve area ? 1 .5 em2 or a >5 % increase in area after the procedure, with a ~2+ grade increase in mitral regurgitation and a left to right shunt (pulmonary/systemic flow ratio <1 .5 :1) . The double-balloon technique was used almost exclusively (n = 3 2) . Mitral moderate and 37 (12%) trained nurse or cardiologist with the referring physician, the Table 2 . Clinical and Morphologic Characteristics of the Study patients, or both. The clinical end points used in this study included 1) mitral valve surgery (valve replacement or repair), 2) repeat balloon mitral valvuloplasty, 3) development of symptomatic heart failure (New York Heart Association functional class III or IV, and 4) death . Causes of death were evaluated from data provided by the patient's physician or medical records. Data aaalysls. Data are expressed as mean value ± SD ; a p value < . 5 was considered significant . All analyses were performed with use of RS1 statistical software (BBN software product) and the survival analysis program BMDP statistical software package . The three groups were compared by using one-way analysis of variance for continuous variables . If no significant difference was detected, no further subgroup analyses were performed . When a significant difference was found, then subsequent to the analyses of variance planned comparisons were conducted to examine differences between individual pair of groups (mild vs . moderate, moderate vs . severe and mild vs. severe) . This technique protects against spurious significant differences due to multiple comparisons (24) . Chisquare analysis was used to compare proportions of patients on the basis of discrete variables . The Fisher exact test was used when all expectations were too small. Kaplan-Meier estimates (25) were used to determine event-free survival (defined as the absence of all four end points defined earlier) . The MantelCox test statistic available in BMDP IL program was used to compare survival curves among groups . Multiple stepwise Cox regression analysis (26) was performed to identify independent predictors of event-free survival . Two separate analyses were performed . The first included only baseline (preprocedural) variables : age, gender, transmittal valve gradient, cardiac output, mitral valve area, left atrial pressure, mean pulmonary pressure, pulmonary artery resistance, mitral regurgitation, fluoroscopic presence of calcium, cardiac rhythm, echocardiographic score, functional class and history of previous commissurotomy. The second model included these variables as well as postprocedural hemodynamic variables, such as final mitral valve area and transmitral pressure gradient . The hazard ratios from the Cox analysis were used to estimate relative risk. Multiple stepwise logistic regression analysis was used to identify independent predictors for initially successful balloon mitral valvuloplasty .
Results
Preprocederal clinical, morphologic and hemodynamic characterist cs . Important clinical, morphologic and hemodynamic variables measured before the procedure in the three groups are shown in Tables 2 and 3 . A higher grade of tricuspid regurgitation was associated with a higher incidence of anal fibrillation and significantly worse functional class before the procedure . Mean right atrial pressure was significantly higher in those patients with severe versus moderate or mild tricuspid regurgitation (11 .8 ± 5.3 vs . 8 .5 ± 4 .7 vs. 6 .7 ± 3 .4 mm Hg, p < . 4) . Immediate results. Percutancous balloon mitral valvuloplasty resulted in substantial increases in mitral valve area (from .93 ± .3 to 1 .9 ± .8 cm). Final mitral valve area 2 :1 .5 was achieved in 227 patients (72%). The overall initial success rate by the criteria defined earlier was 79% and did not differ significantly for the mild (81%), moderate (77%) and severe tricuspid regurgitation (76%) groups . However, the absolute increase in calculated mitral valve area was greater in subjects with mild versus moderate versus severe tricuspid regurgitation (1 . 2 ± .7, .91 ± .5 and .7 ± .5 cm 2, respectively, p < . 1 for mild vs . severe tricuspid regurgitation groups) . The hemodynamic findings after balloon mitral valvotomy are listed in Table 4 . The decrease in transmittal gradient was significantly higher in the group with mild tricuspid regurgitation than in the groups with moderate or severe regurgitation (9 .1 vs. 7.3 vs . 6 .9 mm Hg, respectively, p < . 1) . The final transmitral pressure gradient, mean pulmonary artery pressure and pul- monary vascular resistance were higher in the moderate and severe regurgitation groups than in the mild regurgitation group, whereas the final mitral valve area and cardiac output were significantly lower for the severe versus the mild tricuspid regurgitation group. Clinical follow-up. Follow-up data were available for 3 7 (97%) of the 318 patients. The probability of event-free survival (freedom from death, mitral valve surgery, repeat balloon mitral valvuloplasty and symptomatic heart failure) was significantly lower for the severe tricuspid regurgitation group (Fig . 1) . At 1 year of follow-up the event-free survival rate was 84%, 74% and 61%, respectively, for the mild, moderate and severe tricuspid regurgitation groups . At 4 years the rate was 68%, 58% and 35%, respectively (p < .
1 for mild vs. severe tricuspid regurgitation). A total of 2 deaths had occurred a mean of 39 ± 12 months after balloon mitral valvuloplasty ; 18 deaths were from cardiac causes, 1 was due to lung cancer and 1 had -to known cause . At 4 years 94% of patients with mild tricuspid regurgitation were alive compared with 9 % and 69%, respectively, of patients with moderate or severe tricuspid regurgitation (p < . 1 for mild vs . severe tricuspid regurgitation groups [ Fig . 2] ) . The mortality rate before mitral valve surgery at last contact was significantly lower in the mild versus moderate versus severe tricuspid regurgitation groups (4% vs . 8% vs . 19%, respectively, p < Figure 1 . Kaplan-Meicr estimates of event-free survival rate after balloon mitral valvuloplasty among 318 patients with mild, moderate or severe tricuspid regurgitation (TR). Events were defined as mitral valve surgery, repeat balloon valvuloplasty, New York Heart Association functional class III or IV and death before mitral valve surgery .
. 2 for mild v, severe tricuspid regurgitation) . The need for mitral valve surgery or repeat balloon mitral valvuloplasty was higher for the severe tricuspid regurgitation group, but these differences did not reach statistical significance involving 45 (2 %),13 (22%) and 11(3 %) of patients with mild, moderate or severe tricuspid regurgitation, respectively . Freedom from symptomatic heart failure (functional class III or IV) was greater for the mild tricuspid regurgitation group ; at 4 years, 97% of patients with mild tricuspid regurgitation were free from symptomatic heart failure compared with 94% and 88%, respectively, of patients with moderate or severe tricuspid regurgitation (p < . 4 for mild vs . severe tricuspid regurgitation) .
Predictors of event-free survival . Stepwise multivariate Cox regression analysis of baseline variables identified tricuspid regurgitation as an independent predictor of long-term event-free survival (p < . 5) . The importance of each predictor, relative risks and statistical significance are presented in Table 5 . Increase in tricuspid regurgitation grade from mild to severe was associated with a net 1 .7-fold increase in the risk for adverse end point (an increase by a factor of 1 .3/grade) (1 .3 2 for an increase of two grades) . Other independent preprocedural predictors were previous commissurotomy, functional class, mitral regurgitation and echocardiographic mitral valve score (p < . 5 for all variables). Increase in mitral valve score over the usual range from 4 to 12 was associated with a 2.1-fold increased risk for adverse outcome. When postprocedural variables (final mitral valve area and Table 3 .
regurgitation (TR) .
mitral valve gradient) were included in the multivariate model, tricuspid regurgitation grade remained a significant independent predictor of long-term outcome (p < . 5). Final mitral valve area and transmitral pressure gradient emerged as additional independent predictors of long-term outcome (p < . 5 for both variables).
Discussion
Clinical recognition of the presence, etiology and severity of tricuspid regurgitation associated with mitral stenosis has assumed increasing importance because it affects the outcome of mitral valve surgery (3, 5, 6, 7, 9, 1 ) . The degree of resolution of significant tricuspid regurgitation after correction of mitral stenosis is not always predictable . Although lesser degrees of tricuspid regurgitation are likely to diminish after the mitral lesion is corrected, more severe tricuspid regurgitation may persist and lead to progressive right ventricular dysfunction (6, 7) . Failure to relieve the severity of tricuspid disease is believed to seriously compromise the results of mitral valve operation (6) (7) (8) . Although still controversial, a common surgical practice is to correct significant residual tricuspid regurgitation (by tricuspid valve replacement or annuloplasty) at the time of mitral valve surgery (6, 7, 11, 12) . The intraoperative decision to perform tricuspid annuloplasty when deemed necessary has intervened in the course of the disease so that the impact of significant tricuspid regurgitation on long-term prognosis after mitral valve surgery can now be studied only in those patients not selected for tricuspid valve repair. Recently, however, percutaneous mitral balloon valvuloplasty has emerged as an attractive therapeutic alternative for patients with mitral stenosis (13, 14) . Similar to the early surgical technique of closed valvotomy, it has the potential disadvantage of leaving the associated tricuspid valve disease untreated . Therefore, patients undergoing balloon mitral valvuloplasty constitute a unique patient group that can allow us to evaluate the impact of significant tricuspid regurgitation in mitral stenosis prospectively and without the selection bias introduced by the surgical decision with regard to tricuspid valve repair at the time of mitral valve surgery .
No information is available as to whether significant tricuspid regurgitation is associated with immediate or late adverse outcome of balloon mitral valvuloplasty despite the relatively high prevalence of tricuspid regurgitation in these patients . In the present study we found that 31% of the patients with mitral stenosis undergoing balloon mitral valvuloplasty had associated moderate (19%) or severe (12%) tricuspid regurgitation .
Our results show that patients undergoing balloon mitral valvuloplasty who have severe tricuspid regurgitation have a higher rate of suboptimal immediate results and a significantly poorer event-free survival rate at 4 years of follow-up than that of patients with mild tricuspid regurgitation (68% vs . 35%, p < . term event-free survival after balloon mitral valvuloplasty (p < . 1) . Preprocedural characteristics . A higher grade of tricuspid regurgitation was associated with a higher incidence of atrial fibrillation, moderate mitral regurgitation, symptomatic heart failure and smaller initial mitral valve area . These findings show that significant tricuspid regurgitation is associated with poorer baseline clinical status . Mitral valve score was significantly higher in the groups with moderate or severe tricuspid regurgitation, reflecting more extensive structural and functional disease of the mitral valve apparatus. Increased pulmonary artery pressure and resistance in those with severe tricuspid regurgitation may Maw to the more advanced mitral valve disease . The reduced cardiac output can be a consequence of both the increased right ventricular pressure overload as well as the hemtrdynamically important tricuspid regurgitation, which itself can he a consequence of right ventricular disease . The poorer baseline clinical status in the group with severe tricuspid regurgitation may reflect a combination of more advanced mitral disease as well as hemodynamically important pulmonary hypertension, tricuspid regurgitation and right ventricular failure . Consequently, the presence of significant tricuspid regurgitation identified a subgroup of patients with advanced mitral, pulmonary vascular and right ventricular disease . The fact that in the majority of the patients the tricuspid regurgitation is functional in origin and not due to intrinsic valve abnormality also supports this view .
Immediate results . Success rate as defined earlier did not differ significantly among the tricuspid regurgitation groups .
However, patients with moderate or severe tricuspid regurgitation had less optimal results immediately after the procedure . When optimal success rate was defined as final mitral valve area ? 1 .5 cm 2 without complications (i .e., not including those with a ?5 % increase but with a final mitral valve area < 1 .5 em 2 ), this optimal success rate was significantly lower for subjects with moderate or severe than in those with mild tricuspid regurgitation (69% vs . 62% vs . 51%, respectively, p < . 1 for severe vs . mild tricuspid regurgitation) . Although tricuspid regurgitation was a significant univariate predictor of initial optimal success rate defined in this manner, it was displaced from a multivariate stepwise regression analysis by other established predictors of immediate success, such as mitral valve score, functional class and initial grade of mitral regurgitation. These data indicate that tricuspid regurgitation grade is at most a marker for suboptimal initial results because of its association with higher mitral valve score but cannot serve as an independent predictor for immediate success rate .
Late outcome . The impact of significant tricuspid regurgitation on late outcome in patients undergoing balloon mitral valvuloplasty has not been determined to date . The only available information relating to this question is from follow-up studies of patients after mitral commissurotomy or replacement . Shafie et al . (8) The present finding that patients with severe tricuspid regurgitation undergoing balloon mitral valvotomy have a poorer outcome at late follow-up are in accord with the observations made in patients who underwent mitral valve surgery for mitral stenosis (6, 8, 9, 1 ) . In our patients with balloon mitral valvuloplasty, the severity of tricuspid regurgitation proved to be an independent marker of late outcome . This finding also suggests that in addition to being a marker for a more advanced state of rheumatic mitral disease, tricuspid regurgitation may itself contribute to a poorer prognosis, consistent with previous clinical studies in the surgical setting (6, . Poor late outcome despite an initially successful balloon mitral valvuloplasty in a large number of patients with significant tricuspid regurgitation suggests a possible intrinsic contribution of tricuspid regurgitation to morbidity and mortality in this group .
We can only speculate as to the long-term course of these patients had they undergone mitral valve surgery and tricuspid valve annuloplasty or replacement instead of balloon mitral valvuloplasty. However, the excellent long-term results (freedom from symptomatic heart failure and death) (7, 11, 12) reported in patients with mitral stenosis undergoing tricuspid valve repair for significant tricuspid regurgitation during mitral valve surgery suggest that the surgical approach may be an alternative option for such patients .
Patients with moderate tricuspid regurgitation had a lower event-free survival rate than that of patients with mild tricuspid regurgitation during the first year after the procedure (85% vs . 74%) . However, there was no significant difference between the groups after 4 years of follow-up . This finding may be related to the natural history of tricuspid regurgitation . Initially mild tricuspid regurgitation may increase in severity over the years, changing patients' initially favorable prognosis and reclassifying them in the group with moderate rather than mild tricuspid regurgitation . Another explanation may be simply related to a statistical principle : Regardless of the discrimina-SAGIE ET AL . 7 1 tive power of the grading system, intermediate groups will tend to demonstrate greater variability, rendering them more difficult to distinguish from the extremes.
Other determinants of late outcome after balloon mitral valvuloplasty. Previous studies identified predictors of longterm event-free survival after balloon mitral valvuloplasty to define the subgroups of patients most likely to benefit from this procedure (13, 14, 27, 28) . Among the most important predictors reported are functional class, atrial fibrillation, calcium on fluoroscopy, mitral valve score, mitral regurgitation and left ventricular end-diastolic pressure (27) (28) (29) . In the present study, functional class, mitral regurgitation and echocardicgraphic score were independent predictors for late outcome, a finding consistent with previous reports (28, 29) . We also identified two additional predictors: previous history of mitral commissurotomy and degree of tricuspid regurgitation . The weight of tricuspid regurgitation as a predictor for adverse outcome was comparable to that of the strongest other predictors.
Study limitations . Although follow-up echocardiography was not available in all patients, the lack of resolution of tricuspid regurgitation in patients with significant tricuspid regurgitation (3 ) supports the possibility that persistent tricuspid regurgitation may contribute to poor outcome . Although we cannot definitely conclude that tricuspitd regurgitation itself is the cause of poor clinical outcome (and not other unmeasured factors such as right ventricular impairment), it is at least a significant independent marker for clinical failure and as such can be used for clinical purposes .
Currently, there is no ideal quantitative method availableinvasive or noninvasive-to measure actual tricuspid regurgitant flow . In addition to the limitations of angiography (31) , invasive grading of tricuspid regurgitation requires positioning the catheter across the tricuspid valve, thus interfering with valve competence . Therefore, Doppler echocardiography, especially when integrating information from both the pulsed wave and color technique, seems the most appropriate and readily available tool to assess the severity of tricuspid regurgitation . In addition, estimated pulmonary artery pressure, which can be derived from the tricuspid regurgitation velocities by continuous wave Doppler echocardiography, may add to the predictive power of tricuspid regurgitation severity . The fact that significant prognostic information could be derived from the Doppler color flow mapping of tricuspid regurgitation using the grading algorithm described confirms the usefulness of this noninvasive method . In addition, highly significant differences in mean right atrial pressure determined independently at catheterization were found between our mild, moderate and severe tricuspid regurgitation groups, providing hemodynamic support for this classification .
Conclusions and clinical implications. Patients with severe tricuspid regurgitation undergoing percutaneous balloon mitral valvuloplasty have advanced mitral valve and pulmonary vascular disease, suboptimal immediate results and poor late outcome (4-year major event-free probability of 35%) . These findings support the surgical data of correcting associated severe tricuspid regurgitation during mitral valve surgery. Patients with severe tricuspid regurgitation undergoing percutancous balloon mitral valvuloplasty should be followed up closely with echocardiography . Those patients with persistent severe tricuspid regurgitation at follow-up might be candidates for tricuspid valve surgery.
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